128 related articles for article (PubMed ID: 10561673)
1. Alesse: leading the shift to 20 microg.
Archer DF
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):37-8. PubMed ID: 10561673
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG).
Archer DF; Maheux R; DelConte A; O'Brien FB
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):39-44. PubMed ID: 10561674
[TBL] [Abstract][Full Text] [Related]
3. A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol.
Reisman H; Martin D; Gast MJ
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):45-52. PubMed ID: 10561675
[TBL] [Abstract][Full Text] [Related]
4. The effects on ovarian activity of a monophasic oral contraceptive with 100 microg levonorgestrel and 20 microg ethinyl estradiol.
Coney P; DelConte A
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):53-8. PubMed ID: 10561676
[TBL] [Abstract][Full Text] [Related]
5. Effects of low-dose monophasic levonorgestrel with ethinyl estradiol preparation on serum lipid levels: A twenty-four month clinical trial.
Young RL; DelConte A
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):59-62. PubMed ID: 10561677
[TBL] [Abstract][Full Text] [Related]
6. The effects of a low-dose monophasic preparation of levonorgestrel and ethinyl estradiol on coagulation and other hemostatic factors.
Archer DF; Mammen EF; Grubb GS
Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):63-6. PubMed ID: 10561678
[TBL] [Abstract][Full Text] [Related]
7. Levonorgestrel versus the "Yuzpe" regimen. New choices in emergency contraception.
Lee SM; Dunn S; Evans MF
Can Fam Physician; 1999 Mar; 45():629-31. PubMed ID: 10099801
[TBL] [Abstract][Full Text] [Related]
8. [Back up contraception].
Dacheva T
Akush Ginekol (Sofiia); 2008; 47 Suppl 2():28-31. PubMed ID: 19504704
[No Abstract] [Full Text] [Related]
9. [Escapelle - a method of choice for emergency contraception ].
Tanchev L
Akush Ginekol (Sofiia); 2008; 47 Suppl 2():24-7. PubMed ID: 19496450
[No Abstract] [Full Text] [Related]
10. [Emergency contraception ].
Amaliev G
Akush Ginekol (Sofiia); 2008; 47 Suppl 2():19-24. PubMed ID: 19504703
[No Abstract] [Full Text] [Related]
11. Using a low-dose contraceptive in women 35 years of age and over: 20 microg estradiol/100 microg levonorgestrel.
Carr BR; DelConte A
Contraception; 2002 Jun; 65(6):397-402. PubMed ID: 12127636
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol.
Bjarnadóttir RI; Tuppurainen M; Killick SR
Am J Obstet Gynecol; 2002 Mar; 186(3):389-95. PubMed ID: 11904596
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of low-dose oral contraceptives (with low-doses of ethinyl estradiol), widely used in practice].
Nalbanski B; Tsekova K; Ivanov S
Akush Ginekol (Sofiia); 2001; 41 Suppl 4():20-3. PubMed ID: 11519317
[No Abstract] [Full Text] [Related]
14. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
Rosing J; Middeldorp S; Curvers J; Christella M; Thomassen LG; Nicolaes GA; Meijers JC; Bouma BN; Büller HR; Prins MH; Tans G
Lancet; 1999 Dec; 354(9195):2036-40. PubMed ID: 10636369
[TBL] [Abstract][Full Text] [Related]
15. Hormonal treatment for bleeding irregularities in Norplant implant users.
Alvarez-Sanchez F; Brache V; Thevenin F; Cochon L; Faundes A
Am J Obstet Gynecol; 1996 Mar; 174(3):919-22. PubMed ID: 8633669
[TBL] [Abstract][Full Text] [Related]
16. [Medication of the month. Lowette, a contraceptive for treating acne in young women].
Goffin V; Piérard-Franchimont C; Piérard GE
Rev Med Liege; 2003 Apr; 58(4):261-3. PubMed ID: 12868331
[TBL] [Abstract][Full Text] [Related]
17. International clinical experience with a new low-dose, monophasic oral contraceptive containing levonorgestrel 100 microg and ethinyl estradiol 20 microg.
Boerrigter PJ; Ellman H; Dolker M
Clin Ther; 1999 Jan; 21(1):118-27. PubMed ID: 10090429
[TBL] [Abstract][Full Text] [Related]
18. Risk factors of cardiovascular disease among the oral contraceptive users in Kermanshah City of Iran.
Malek-Khosravi S
J Pak Med Assoc; 2008 Aug; 58(8):473-4. PubMed ID: 18822656
[No Abstract] [Full Text] [Related]
19. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
Christie T
J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701
[No Abstract] [Full Text] [Related]
20. An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 microg ethinyl estradiol and 100 microg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variables.
Endrikat J; Klipping C; Cronin M; Gerlinger C; Ruebig A; Schmidt W; Düsterberg B
Contraception; 2002 Mar; 65(3):215-21. PubMed ID: 11929643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
